Login to Your Account



Not 'Growthy,' Tax-Wise Deal: Actavis Takes Warner Chilcott

By Randy Osborne
Staff Writer

Monday, May 20, 2013

Generic drugmaker Actavis Inc.'s plan to take over Dublin-based Warner Chilcott plc in a stock-for-stock transaction worth about $8.5 billion, thus forming the world's third-largest specialty pharmaceutical firm, would put the combined firm – with about $11 billion in annual revenues.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription